NCT00679224已完成不适用
A Post-Marketing Observational Surveillance Programme for Ambrisentan (VOLT)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 800
- 试验地点
- 1
- 主要终点
- safety monitoring
研究概览
简要总结
The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice
详细描述
The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
ambrisentan prescribed subjects
ambrisentan prescribed subjects
干预措施: ambrisentan (Drug)
结局指标
主要结局
safety monitoring
次要结局
- safety monitoring
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Lyrica (Pregabalin) Korean Post Marketing Surveillance StudyNeuropathic PainPost-market SurveillanceEpilepsyFibromyalgiaNCT01220180Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4,175
招募中
不适用
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasNCT04750798Biosense Webster, Inc.8,000
已完成
不适用
MANTA Registry for Vascular Large-bore ClosureFemoral Arteriotomy ClosureNCT03330002Essential Medical, Inc.500
已完成
不适用
ULTIVA Post Marketing SurveillanceAnalgesiaNCT01299584GlaxoSmithKline775
已完成
不适用
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaHepatitis C VirusNCT02907996Gilead Sciences2,033